Astrin Biosciences, a cancer intelligence company transforming how cancer is detected and treated through deep proteomics and AI, today announced the publication of a landmark peer-reviewed study, ...
Lyme disease is a high-incidence infectious disease with a global prevalence of 14.5% of the world's population. Two-tier serology is currently the primary diagnostic test for Lyme disease; however, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results